Delivery Order SPE2DB24D2105-SPE2DB25FAQBC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,066.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The product will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.52 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on June 24, 2025, with completion targeted for June 25, 2025. This competitively awarded, firm fixed-price delivery order represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,822.99 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,383.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This non-competitive delivery order, with an ultimate completion date of July 15, 2025, represents a small-value pharmaceutical transaction supporting federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,525.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections on July 24, 2025. This firm fixed-price, competitively awarded contract is classified as a delivery order with no set-aside designation and carries an ultimate completion date of July 25, 2025. The pharmaceutical product will be performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a contract ceiling value of $7,412.22 and an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the vendor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $10,814.13 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors with a completion date of June 2, 2025. This non-set-aside competitive award represents a continuation of services under AmerisourceBergen's broader pharmaceutical supply arrangement with the federal government. The delivery order is being fulfilled from the company's place of business in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.28 for Zepbound 2.5 mg/0.5 mL pen injections, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under a larger vehicle within the federal pharmaceutical supply chain supporting military and defense healthcare needs....
- The Defense Logistics Agency awarded a $27,085.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. This is a competitive award with no set-aside designation, with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp will perform the contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,522.24 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections. The contract, which is non-set-aside and competitively awarded, was executed on August 31, 2025, with an ultimate completion date of September 2, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order operates under a firm fixed-price...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQBCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,836.76 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen's consistent receipt of competitively awarded federal contracts demonstrates its capability to fulfill critical medical supply requirements for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.8k | 8/11/25 |